6:12 PM
 | 
Dec 10, 2012
 |  BC Extra  |  Company News

Gill named CEO of TransCelerate

TransCelerate BioPharma Inc. (Philadelphia, Pa.) named Dalvir Gill as CEO, effective Jan. 1, 2013. Gill was president of Phase II-IV drug development at CRO PharmaNet Development Group...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >